Newron drops development of sarizotan in Rett syndrome

5th May 2020 Uncategorised 0

The experimental 5-HT1A receptor agonist and D2 receptor antagonist was not effective on primary or secondary endpoints

More: Newron drops development of sarizotan in Rett syndrome
Source: News